SEER - NASDAQ

Seer, Inc.

SEER·NASDAQ

$1.86

-0.26%

HealthcareBiotechnology

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$102.54M

EPS-1.2800

P/E Ratio-1.46

Earnings Date08/05/2026

296.08M

Assets

-19%

3Y-39.0%

5Y-33.0%

10Y+779.0%

36.78M

Total Liabilities

-6%

3Y-10.0%

5Y+243.0%

10Y+888.0%

259.31M

Total Equity

-21%

3Y-42.0%

5Y-40.0%

10Y+765.0%

Seer, Inc. Funding & Solvency Profile

SEER · NASDAQ

Current Assets

Cash & Cash Equivalents47.28M

Net Receivables5.65M

Inventory7.79M

Other Current Assets2.19M

Total Current Assets202 M

Non-Current Assets

Property, Plant & Equipment35.24M

Goodwill & Intangible Assets0.00

Long-Term Investments54.69M

Other Non-Current Assets4.62M

Total Non-Current Assets95 M

Total Assets

296.08M

Financial Health Analysis

Current Ratio

12.84x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.14x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

186 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

68% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Seer, Inc. Balance Sheet

SEER • NASDAQ

Seer, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	47.3M	40.8M	32.5M	53.2M	232.8M	333.6M	17.5M	31M
Short-Term Investments	138.6M	195.7M	283.7M	368M	167.3M	98.3M	68.5M	0.0
Cash & Short-Term Investments	185.9M	236.4M	316.2M	421.2M	400.1M	431.9M	86M	31M
Net Receivables	5.7M	6.2M	6.7M	7M	4.1M	262K	326K	69K
Accounts Receivables	0.0	4M	4.8M	4.3M	2.5M	0.0	0.0	0.0
Other Receivables	5.7M	2.2M	1.9M	2.7M	1.6M	262K	326K	12K
Inventory	7.8M	7.4M	4.5M	4.6M	4.1M	551K	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	3.3M	0.0	460K	190K
Other Current Assets	2.2M	3.2M	3.1M	2.1M	0.0	452K	0.0	0.0
Total Current Assets	201.5M	253.3M	330.5M	435M	411.7M	433.1M	86.8M	31.2M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	35.2M	41.4M	47.4M	46.4M	33.2M	8.4M	5.7M	2.4M
Long-Term Investments	54.7M	63.1M	56.9M	5.2M	93.2M	343K	343K	0.0
Other Non-Current Assets	4.6M	8.8M	1.5M	1.4M	1M	407K	400K	124K
Total Non-Current Assets	94.5M	113.3M	105.8M	52.9M	127.4M	9.2M	6.4M	2.5M
Total Assets	296.1M	366.6M	436.3M	487.9M	539.1M	442.3M	93.2M	33.7M
LIABILITIES
CURRENT LIABILITIES
Total Payables	5.6M	5.1M	1.9M	2.4M	4.2M	2.1M	701K	2.6M
Accounts Payable	5.6M	4.6M	1.4M	2.1M	3.8M	2.1M	701K	2.6M
Other Payables	0.0	471K	501K	335K	457K	0.0	0.0	0.0
Accrued Expenses	0.0	6M	6.1M	1.8M	3.2M	2.9M	1.3M	722K
Short Term Debt	2.6M	2.3M	2.3M	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	0.0	0.0	1.8M	864K	0.0	0.0	0.0
Tax Payables	0.0	471K	501K	335K	457K	0.0	0.0	0.0
Deferred Revenue	341K	408K	206K	133K	376K	250K	175K	0.0
Other Current Liabilities	7.2M	1.5M	2.7M	6.3M	4.7M	2.9M	1.6M	344K
Total Current Liabilities	15.7M	15.3M	13.2M	12.6M	13.4M	8.1M	3.8M	3.7M
NON-CURRENT LIABILITIES
Long Term Debt	21.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	8K	48K	179K	320K	341K	2.6M	1.7M	30K
Total Non-Current Liabilities	21.1M	23.7M	26.1M	28.4M	22.8M	2.6M	1.7M	30K
Capital Lease Obligations	0.0	23.7M	26M	29.9M	23.3M	0.0	0.0	0.0
Total Liabilities	36.8M	39M	39.4M	40.9M	36.2M	10.7M	5.6M	3.7M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	108M	35.8M
Common Stock	1K	1K	1K	1K	1K	1K	0.0	0.0
Additional Paid-In Capital	0.0	719.8M	702.9M	667.7M	630M	486.9M	2.3M	711K
Retained Earnings	-466M	-392.4M	-305.8M	-219.5M	-126.5M	-55.4M	-22.6M	-6.5M
Accumulated Other Comprehensive Income/Loss	0.0	136K	-192K	-1.3M	-536K	54K	24K	-31K
Other Total Stockholders' Equity	725.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	259.3M	327.6M	396.9M	447M	502.9M	431.6M	87.7M	30M
Total Equity	259.3M	327.6M	396.9M	447M	502.9M	431.6M	87.7M	30M
SUMMARY
Total Liabilities & Equity	296.1M	366.6M	436.3M	487.9M	539.1M	442.3M	93.2M	33.7M
Total Investments	193.3M	258.8M	340.6M	373.2M	260.4M	98.6M	68.5M	0.0
Total Debt	23.7M	26M	28.3M	29.9M	23.3M	0.0	0.0	0.0
Net Debt	-23.6M	-14.8M	-4.2M	-23.3M	-209.5M	-333.6M	-17.5M	-31M
Shares Outstanding	56,344,253	56,344,253	56,344,253	56,344,253	56,344,253	56,344,253	56,344,253	56,344,253

SEC Filings

SEER - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 22, 2026	May 21, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 13, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 13, 2026	May 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 04, 2026	2026	View Filing
10-K/A 10-K/A 2025 FY (Amended) FY	April 30, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 13, 2026	April 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 30, 2026	March 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 16, 2026	March 13, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 02, 2026	December 31, 2025	2025	View Filing

Showing 1 to 10 of 85 filings

Related Guides

Blog Categories

Continue your SEER research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.